Provox ActiValve for Laryngectomy

This trial tests the Provox® ActiValve® (a voice prosthesis device) to determine if it can reduce the frequency of voice prosthesis replacements each year for individuals who have undergone a total laryngectomy. Participants will use the Provox ActiValve in various ways to identify the optimal replacement schedule. This trial targets those who have had a laryngectomy with a tracheoesophageal puncture and are using or ready to use a voice prosthesis, with no signs of cancer in the head and neck area. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance the quality of life for others with similar conditions.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that the Provox ActiValve is generally well-tolerated by patients who have had their voice box removed. Previous studies have demonstrated its successful use in helping people speak again. Although a few reports of problems exist, such as one instance where the device was accidentally inhaled, these issues are rare. Most users do not experience serious problems. Overall, the Provox ActiValve is considered safe and is commonly used in regular care for similar conditions.¹²³⁴⁵

Researchers are excited about the Provox® ActiValve® for laryngectomy patients because it offers a unique approach to voice prosthesis management. Unlike standard indwelling voice prostheses, which might require frequent replacements due to leakage or other issues, the Provox ActiValve is designed to minimize these problems with its innovative valve mechanism. This special valve aims to reduce the need for frequent device changes, offering a more convenient and potentially longer-lasting solution for individuals who have undergone a laryngectomy. Additionally, the option for prophylactic exchange ensures that the device is replaced before any issues arise, providing peace of mind and potentially enhancing the quality of life for patients.

Research has shown that the Provox® ActiValve® reduces the frequency of voice prosthesis replacements after a total laryngectomy. In this trial, participants may be randomized to receive the Provox ActiValve in different treatment arms, including routine "as needed" exchange, standard indwelling VP with optional cross-over, or prophylactic exchange. Studies have found the Provox ActiValve to be a cost-effective choice, especially for those who frequently experience device leaks. In more than 90% of patients, the Provox ActiValve successfully restores the ability to speak. This device not only aids in voice recovery but also reduces the inconvenience of frequent replacements. Overall, the Provox ActiValve offers a dependable way to improve the quality of life for patients using voice prostheses.⁵⁶⁷⁸⁹